🚀💥 $SNDK just delivered one of the cleanest options alpha prints of 2026 and the tape tells me this move was not random, it was structured, hedged, and dealer driven.
🚀 You could have turned $317 into $4,001 on $SNDK with options
On 05Jan26 the $400 call for the 30Jan26 expiry traded at $3.17, over 130% OTM. Today it printed $40.01 with spot pushing into the $388 to $395 zone. That is a 1,162% return in seven trading days. This is gamma, delta and volatility doing the heavy lifting, not luck.
📈 I am watching the $400 strike because it has become the dominant dealer pivot. That strike is where hedging pressure accelerates and price starts feeding on itself through gamma expansion. This is exactly how parabolic continuations are born in momentum tech and AI infrastructure names.
🔥 $SNDK is now up over 63.59% YTD and still in price discovery after a historic 2025. I am seeing persistent call demand, positive gamma above spot, and rising implied volatility into strength. That combination is what keeps upside squeezes alive.
🧠 I am focused on how options flow is now steering the underlying. When market makers are forced to chase deltas into rising price, it creates reflexive upside. That is why this rally keeps stair stepping higher instead of fading.
⚡️ Momentum, AI memory exposure, and derivatives positioning are now fully aligned. This is the kind of structure that keeps attracting fast money, systematic flows, and trend followers all at once.
📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀
Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
@Tiger_comments @TigerObserver @Daily_Discussion @TigerPicks @TigerStars @TigerWire
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
High-Correlation Event
NVIDIA-Eli Lilly $1B AI Drug Discovery Lab
Impact Summary:
Short-term: Neutral-to-positive sentiment (93% forum bullishness) may counter CES-driven declines, but market greed phase (Fear & Greed Index: 60.19) increases volatility sensitivity.
Long-term: High-potential diversification into AI-driven drug discovery, enhancing NVIDIA's ecosystem beyond core chips via BioNeMo adoption.
Risk: Regulatory scrutiny in healthcare AI and execution challenges in biotech integration remain unmonitored variables.
Medium-Correlation Event
CES Announcement Reaction & Market Sentiment
Integrated Impact: Combined with high-correlation events, short-term pressure from underwhelming CES responses is partially offset by strategic partnership optimism.
Final Summary
Multiple medium/high-correlation events:
Short-term: Volatility from market-wide risks (geopolitical/Fed concerns) and sector rotation, mitigated by strong AI partnership news.
Long-term: Strategic expansion into AI-pharma strengthens competitive moat, though dependent on cross-industry execution.
Risk: Overlooked policy shifts in AI healthcare and supply-chain disruptions for Vera Rubin chips.
很棒的文章，你愿意分享吗？
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?